Labeling of proliferating cells one week after stroke using 5-ethynyl-2’-deoxyuridine (EdU) injections combined with immunofluorescent labeling of PECAM1+ ECs showed that Apold1−/− ECs within the ischemic border zone proliferate less (Fig. 3G, I). The gene discussed is PECAM1; the disease is stroke disorder.